Patents/Assignees

REGENRON PHARMACEUTICALS, Inc.

1 patent in portfolio

US12280093utility2025
Use of a VEGF Receptor-based Fusion Protein Antagonist to Treat Nonproliferative Diabetic Retinopathy
0 cites